|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
68
|
|
pubmed:dateCreated |
2006-4-12
|
|
pubmed:abstractText |
To observe the recurrence and prognosis of patients with hepatocellular carcinoma (HCC) coexisting with chronic hepatitis B infection with active virus replication after receiving antivirus therapy using lamivudine and thymosin alpha1 postoperatively.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0172-6390
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
249-52
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16608033-Adjuvants, Immunologic,
pubmed-meshheading:16608033-Adult,
pubmed-meshheading:16608033-Carcinoma, Hepatocellular,
pubmed-meshheading:16608033-Drug Therapy, Combination,
pubmed-meshheading:16608033-Female,
pubmed-meshheading:16608033-Follow-Up Studies,
pubmed-meshheading:16608033-Hepatectomy,
pubmed-meshheading:16608033-Hepatitis B, Chronic,
pubmed-meshheading:16608033-Humans,
pubmed-meshheading:16608033-Lamivudine,
pubmed-meshheading:16608033-Liver Neoplasms,
pubmed-meshheading:16608033-Male,
pubmed-meshheading:16608033-Middle Aged,
pubmed-meshheading:16608033-Prospective Studies,
pubmed-meshheading:16608033-Reverse Transcriptase Inhibitors,
pubmed-meshheading:16608033-Survival Rate,
pubmed-meshheading:16608033-Thymosin
|
|
pubmed:articleTitle |
Antiviral therapy using lamivudine and thymosin alpha1 for hepatocellular carcinoma coexisting with chronic hepatitis B infection.
|
|
pubmed:affiliation |
Eastern Hepatobiliary Surgery Institute, Eastern Hepatobiliary Surgery Hospital The Second Military Medical University, Shanghai 200438, P. R. China. chengshuqun@yahoo.com.cn
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
